Osel Sees Immunotherapy-Like Trajectory For Oncology Microbiome Candidate

 
• By Alaric DeArment
  
Bacterias 3D rendering
Osel announced results of a Phase I trial combining its microbiome therapy with BMS's Opdivo • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas